A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 185
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : WIN
Long Form : WIN 55,212-2
No. Year Title Co-occurring Abbreviation
2020 Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine. NAcc, PFC
2020 Cannabinoid Receptor Agonist WIN55, 212-2 Adjusts Lipid Metabolism in a Rat Model of Cardiac Arrest. CA, Cer, FFA, LPC, NT, PH, ROSC, WN
2020 Cannabinoid Signaling Recruits Astrocytes to Modulate Presynaptic Function in the Suprachiasmatic Nucleus. A1Rs, CB1R, DREADDs, SCN
2020 Cannabinoid-mediated Modulation of Oxidative Stress and Early Inflammatory Response after Hypoxia-Ischemia. CB, CNS, ECS, HI, IL, ROS, TNF
2020 Intracerebellar cannabinoid administration impairs delay but not trace eyeblink conditioning. EBC, ISI
2020 Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling. ---
2020 The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling. ASK1, CAT, CCH, Cyt C, MDA, NeuN, ROS, SOD
2019 Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood. ---
2019 Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner. ---
10  2019 Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture. ---
11  2019 Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood. mPFC, PFC, PR
12  2019 Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. ATP, CB, HAND, IL, PGC-1alpha, PPAR, TFAM
13  2019 Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats. DMSO, PB
14  2019 Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors. ---
15  2019 Synergistic action of CB1 and 5-HT2B receptors in preventing pilocarpine-induced status epilepticus in rats. eCBs, PILO, RO, SE
16  2019 Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2. ER, HdF, SCBs
17  2019 WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner. SPARC
18  2018 A Cannabinoid Receptor Type 1 (CB1R) Agonist Enhances the Developmental Neurotoxicity of Acetaminophen (Paracetamol). AAP, CB1R, FAAH, SYP, TRKB
19  2018 Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats. ACRS, eCB, NAc, PD
20  2018 Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood. ---
21  2018 Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism. ASD, CB1, EPSCs, IPSCs, NL3
22  2018 Cannabinoid Receptor Type 1 Expression in the Developing Avian Retina: Morphological and Functional Correlation With the Dopaminergic System. 2-AG, cAMP, DSs, GCL, IPL, MAGL, PE7, TH
23  2018 Cannabinoid Receptors Modulate Excitation of an Olfactory Bulb Local Circuit by Cortical Feedback. CBR, CFF, dSACs, DSE, GCL, GCs, MCs, OB, TCs
24  2018 Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice. CB1R, eCB, EtOH
25  2018 Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. eCB, IL-1beta, LPS, mRNA, RSD
26  2018 Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats. ERK, PFCx
27  2018 Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer. DOXO, TNBC
28  2018 The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia. 2VO, IL-1beta, LC3, RT-PCR, TNF-alpha, VaD
29  2017 Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice. ---
30  2017 Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats. CB1Rs, DMSO, i.p, METH
31  2017 Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-kappaB pathways. CCH, COX-2, GFAP, IkappaB-a, IL-1beta, iNOS, NF-kappaB, ROS, TNF
32  2017 Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala. BLA
33  2017 Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats. i.p
34  2017 Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory. SA
35  2017 Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats. CPZ, i.p, TRPV1
36  2017 May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat. 5-FU, i.p
37  2017 Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure. CB, CB1R, CCK-INTs, THC
38  2017 The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function. ---
39  2017 The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit. BLA, IC
40  2016 Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory synaptic transmission in rat inner retina. ACs, BCs, CB1R, mEPSCs, mIPSCs, RGCs
41  2016 Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor. CBR
42  2016 Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling. BAD, BDNF, CB1, CCH, CREB, FAAH, FoxO, GAP, GSK, MAP, MGL, NAPE-PLD, PI3K
43  2016 Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal-Accumbens Plasticity After Stress. BLA, CREB, GR, HPA, LTP, NAc, RU, vSub
44  2016 Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. BLA, CB1R, ES, GRs, PFC
45  2016 Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala. CeA, eCBs
46  2016 Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. A2ARs, CB1Rs, WT
47  2016 The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism. VTA
48  2016 The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells. ER, SPARC, TRAIL
49  2016 Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. ACh, AD, APP, JWH
50  2016 WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals. COX-2, EMT, GC
51  2016 [Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells]. MMP-14, p-AKT, p-ERK
52  2015 Activation of type-1 cannabinoid receptor shifts the balance between excitation and inhibition towards excitation in layer II/III pyramidal neurons of the rat prelimbic cortex. CP, eCB, mPFC, PL
53  2015 Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation. CBRs, LPS
54  2015 Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling. Bax, BCCAO, Bcl, CCH, ECS, ERK, JNK
55  2015 Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain. CBR, ECS, KP, NMDAR, QUIN, ROS
56  2015 Cannabinoid-induced chemotaxis in bovine corneal epithelial cells. 2-AG, bCECs, CECs, DAGLalpha, MAPK
57  2015 Effect of styrene maleic acid WIN55,212-2 micelles on neuropathic pain in a rat model. SMA
58  2015 In vitro and non-invasive invivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat. CB1R, GI
59  2015 The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes. CBR, ECS, GA, MMA, NMDAR, OAs, ROS
60  2015 The endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways. CB, ECS, HP
61  2015 The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3beta Phosphorylation in Cerebellar Granular Neurons of Rat. AM251, CB1, CGNs, FSK, GSK-3beta, Li
62  2015 The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer. SMA
63  2014 Alterations in the intrinsic burst activity of Purkinje neurons in offspring maternally exposed to the CB1 cannabinoid agonist WIN 55212-2. ---
64  2014 Cannabinoid type-1 receptor ligands, alone or in combination with cocaine, affect vigilance-related behaviors of marmoset monkeys. CB1r, eCB, NHPs, WD
65  2014 Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. DA, MAM, Sal, VTA
66  2014 Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors. 2-AG, AEA, FAAH, MGL
67  2014 Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells. CAS
68  2014 Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats. DA, PFC
69  2014 Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms. LFPs, mPFC, SCx
70  2014 WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARgamma down-regulation. LMP, PPARgamma
71  2013 Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. 2-AG, CAP, CB1, HCEC, PTX, TAK1, TRPV1, WT
72  2013 Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test. CB1r, OF
73  2013 Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. BLA, GR, HPA, PFC, SPS
74  2013 Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat. GI
75  2013 Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy. ---
76  2013 Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. SA, VEH
77  2013 Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making. MDMA
78  2013 Dual role of PPAR-gamma in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2. B.S
79  2013 Involvement of cannabinoid receptors in the amygdala and prefrontal cortex of rats in fear learning, consolidation, retrieval and extinction. BLA, CB1R, mPFC
80  2013 Novel song-stimulated dendritic spine formation and Arc/Arg3.1 expression in zebra finch auditory telencephalon are disrupted by cannabinoid agonism. IEG, Ov
81  2013 PPARgamma mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells. HCC, PARP
82  2013 Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors. CB1R, ERK, MAPK, PKA, TEA
83  2013 The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. EGFR, miR-27a, PP2A, RNAi, Sp
84  2012 A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. TMEV, TMEV-IDD
85  2012 Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats. CB1, GABA, GAD67, NTS
86  2012 Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. ASR, BLA, HPA, IA, PTSD, SPS
87  2012 Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. ZDF
88  2012 Destructive Effects of Prenatal WIN 55212-2 Exposure on Central Nervous System of Neonatal Rats. ---
89  2012 Effect of ion pairing on in vitro transcorneal permeability of a Delta(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy. HP-beta-CD, RMbetaCD, THC-HS
90  2012 Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats. BBB, IC, MCA
91  2012 Epileptiform activity in the CA1 region of the hippocampus becomes refractory to attenuation by cannabinoids in part because of endogenous gamma-aminobutyric acid type B receptor activity. ---
92  2012 Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. DA, IPSCs, RMTg, VTA
93  2012 Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. CB1R, MCAO
94  2012 Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior. CB1, ECS
95  2012 Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. LTP, NAc, vSub
96  2012 Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. CB1, DGL, eCB, FAAH, MGL, mGluR5, VEH
97  2012 Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. CB1Rs, HD
98  2011 Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. AD, CBD, HU, JWH
99  2011 Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness. 2-AG
100  2011 Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. EMT, EPM, PD